Rolf W. Sparidans

Papers

Total Citations

H-Index

About

Rolf W. Sparidans is a leading analytical chemist whose research focuses on the development and validation of bioanalytical methods, particularly for the quantification of drugs and their metabolites in biological matrices. His major contributions lie in advancing liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques for pharmacokinetic studies, with a special emphasis on anticancer agents and bisphosphonates. Notably, his work on the semi-automatic liquid chromatographic analysis of olpadronate—a bisphosphonate used in bone diseases—demonstrated innovative derivatization strategies using (9-fluorenylmethyl)chloroformate, achieving sensitive detection in urine and serum. This foundational study, cited 19 times, exemplifies his meticulous approach to method development. Sparidans has also made significant strides in quantifying tyrosine kinase inhibitors and other targeted therapies, enabling precise drug monitoring in clinical settings. His research has been instrumental in bridging analytical chemistry and pharmacology, supporting personalized medicine. With a career spanning over two decades, his methods are widely adopted in academic and pharmaceutical laboratories, reflecting his lasting impact on bioanalysis. His work continues to inspire students and researchers in the field of pharmaceutical analysis.